Skip to content
★ Sign in to follow
PS

Peder Svensson

IRLAB Therapeutics AB
Total declarations
4
Company
1
▲ Purchases (2 ops.)
€6,317
▼ Sales (0 ops.)
—

Latest filing published 11 Jul 2019 for IRLAB Therapeutics AB, €272k.

Filing timeline

BuySale
Peder Svensson

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Peder Svensson: trading record in brief

All filings by Peder Svensson on record concern IRLAB Therapeutics AB. We count 4 filings; the first trade dates from 14 February 2017 and the latest from 10 July 2019.

Purchases make up the whole of the open-market record (2 purchases, €6,317). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

Most recently, on 11 July 2019, the filings show a transaction worth €272k in IRLAB Therapeutics AB. The most recent open-market purchase was published on 27 February 2017, 3,542 days ago. The median gap between a trade and its publication by Finansinspektionen is 2 days. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Peder Svensson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    Director of Computational Chemistry & Biology, CIOExecutivesIRLAB Therapeutics AB
    3M SEK0FI-SE
    31,299 shares@ SEK 92.18AktieISIN SE0012675361FI:csv-e0ab1a0bef2b8140c665
  • ▲
    Director of Computational Chemistry & Biology, CIOExecutivesIRLAB Therapeutics AB
    30,000 SEK0FI-SE
    500 shares@ SEK 60.00ISIN SE0009242225FI:csv-685d54c5de8aacca6f13
    Canonical exit: 25 May 2017 (T+90)
  • ▲
    Director of Computational Chemistry & Biology, CIOExecutivesIRLAB Therapeutics AB
    30,000 SEK0FI-SE
    500 shares@ SEK 60.00ISIN SE0009242225FI:csv-ac56f8bc0efeabcf4dcd
    Canonical exit: 15 May 2017 (T+90)

3 of 3 declarations